MicroRNA Circuits in Transforming Growth Factor-beta Actions and Diabetic Nephropathy

作者：Kato Mitsuo; Natarajan Rama^*

来源：Seminars in Nephrology, 2012, 32(3): 253-260.

DOI：10.1016/j.semnephrol.20l2.04.004

• MicroRNAs
• TGF-beta
• diabetic nephropathy
• fibrosis
• hypertrophy

Diabetes is associated with significantly increased rates of kidney disease or diabetic nephropathy (DN), a severe microvascular complication that can lead to end-stage renal disease. End-stage renal disease needs to be treated by dialysis or kidney transplantation and also is associated with cardiovascular disease and macrovascular complications. Therefore, effective renal protection is critical to reduce the rates of mortality associated with diabetes. Although key signal transduction and gene regulation mechanisms have been identified and several drugs are currently in clinical use, the rates of ON are still escalating, suggesting the imperative need to identify new biomarkers and drug targets. The recent discovery of microRNAs (miRNAs) and their cellular functions provide an opportunity to fill these critical gaps. Because miRNAs can modulate the actions of key factors involved in ON such as transforming growth factor-beta, they could be novel targets for the treatment of DN. This review covers the recent studies on the roles of miRNAs and miRNA circuits in transforming growth factor-beta actions and in DN.

• 出版日期2012-5